Back

Efficacy and safety of oral acetazolamide in patients with decompensated heart failure: hospital phase of open-label prospective randomized multicenter study ORION-A

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Aggressive ways of saving patients Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Ibragim Sabirov

Kyrgyz-Russian Slavic University, Bishkek (Kyrgyzstan)

9 More presentations in this session

Presentation thumbnail
Discussant - Aggressive ways of saving patients
Presentation thumbnail
Prognostic significance of histological diagnosis in acute myocarditis with fulminant presentation
Doctor Y. Takei (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Novel semi-invasive pressure-volume loop analysis for hemodynamic assessment and risk stratification across SCAI stages in cardiogenic shock
Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Impact of the combined use of VA-ECMO and impella (ECPELLA) on short-term mortality in cardiogenic shock patients receiving VA-ECMO: a propensity score-matched analysis
Doctor T. Inamori (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Beta-blockers after myocardial infarction: are we treating without evidence? a systematic review and meta-analysis
Doctor R. Ferreira Gomes (Recife, BR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Aggressive ways of saving patients

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Combination oral acetazolamide and intravenous furosemide on acute decompensated heart failure
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Session
Pharmacotherapy for worsening heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources